1,457
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: Lung Cancer

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

, , , , , , , , , , , , & show all
Pages 140-148 | Received 01 Jan 2015, Accepted 29 Apr 2015, Published online: 10 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Haim Werner, Rive Sarfstein & Ilan Bruchim. (2019) Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy. Expert Opinion on Investigational Drugs 28:12, pages 1101-1112.
Read now

Articles from other publishers (11)

Panpan Wang, Victor CY. Mak & Lydia WT. Cheung. (2023) Drugging IGF-1R in cancer: New insights and emerging opportunities. Genes & Diseases 10:1, pages 199-211.
Crossref
Syuan-Ling Lin, Chih-Yang Lin, Wei Lee, Chiao-Fang Teng, Woei-Cherng Shyu & Long-Bin Jeng. (2022) Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine. International Journal of Molecular Sciences 23:19, pages 11781.
Crossref
Xiongye Xu, Yanli Qiu, Simin Chen, Shuaishuai Wang, Ruifu Yang, Baomo Liu, Yufei Li, Jiating Deng, Yan Su, Ziying Lin, Jincui Gu, Shaoli Li, Lixia Huang & Yanbin Zhou. (2022) Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer. Current Pharmaceutical Design 28:25, pages 2052-2064.
Crossref
Mohammed A. Mansour, Valentina S. Caputo & Eiman Aleem. (2021) Highlights on selected growth factors and their receptors as promising anticancer drug targets. The International Journal of Biochemistry & Cell Biology 140, pages 106087.
Crossref
Fenfang Liao, Yongheng Chen, Qingqing Wu, Jiaqi Wen, Xiangjie Chen, Weizhang Wang, Dan Xu & Manyu Liu. (2021) Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation. Biochemical and Biophysical Research Communications 579, pages 1-7.
Crossref
Kaleb B. Tsegay, Christiana M. Adeyemi, Edward P. Gniffke, D. Noah Sather, John K. Walker & Stephen E. P. Smith. (2021) A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2. Frontiers in Pharmacology 12.
Crossref
Anna Ianza, Marianna Sirico, Ottavia Bernocchi & Daniele Generali. (2021) Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Anhao Tian, Bo Kang, Baizhou Li, Biying Qiu, Wenhong Jiang, Fangjie Shao, Qingqing Gao, Rui Liu, Chengwei Cai, Rui Jing, Wei Wang, Pengxiang Chen, Qinghui Liang, Lili Bao, Jianghong Man, Yan Wang, Yu Shi, Jin Li, Minmin Yang, Lisha Wang, Jianmin Zhang, Simon Hippenmeyer, Junming Zhu, Xiuwu Bian, Ying‐Jie Wang & Chong Liu. (2020) Oncogenic State and Cell Identity Combinatorially Dictate the Susceptibility of Cells within Glioma Development Hierarchy to IGF1R Targeting. Advanced Science 7:21, pages 2001724.
Crossref
Christabel Wilson, Mhairi Nimick, Hayley Nehoff & John C. Ashton. (2017) ALK and IGF-1R as independent targets in crizotinib resistant lung cancer. Scientific Reports 7:1.
Crossref
Robert Aiken, Magnus Axelson, Johan Harmenberg, Maria Klockare, Olle Larsson & Cecilia Wassberg. (2017) Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response. Oncotarget 8:46, pages 81501-81510.
Crossref
Anastassios Philippou, Panagiotis F. Christopoulos & Dr. Michael Koutsilieris. (2017) Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer. Mutation Research/Reviews in Mutation Research 772, pages 105-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.